N05.6
Unspecified nephritic syndrome with dense deposit disease
Clinical Classification Guidelines
Inclusion Terms
- Unspecified nephritic syndrome with C3 glomerulopathy with dense deposit disease
- Unspecified nephritic syndrome with membranoproliferative glomerulonephritis, type 2
Medical Intelligence & Overview
Unspecified nephritic syndrome with dense deposit disease is a kidney disorder characterized by inflammation of the glomeruli, the tiny filters within the kidneys. This condition involves complex immune reactions that damage these filters, leading to impaired kidney function. The term encompasses a specific subset of nephritic syndromes associated with dense deposit disease, also known as C3 glomerulopathy, which affects the structure of the glomeruli at a microscopic level. Recognizing and understanding this condition can help in managing the symptoms and underlying causes, though treatment approaches should always be guided by a healthcare professional.
Causes & Symptoms
Clinical Causes: Dysregulation of the immune system, leading to abnormal activation of the complement pathway Genetic mutations affecting complement regulation proteins Infections triggering immune responses that damage the kidneys Autoimmune processes that target kidney tissue Secondary causes such as other systemic diseases or medications
Key Symptoms: Swelling in the legs, ankles, or around the eyes (edema) Blood in the urine (hematuria) Foamy or dark-colored urine due to proteinuria High blood pressure (hypertension) Reduced urine output or difficulty urinating Fatigue and general malaise Occasional kidney pain or discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition typically involves a combination of medical history review, physical examination, and laboratory tests. Urinalysis can detect blood and protein in the urine, while blood tests can assess kidney function by measuring creatinine and blood urea nitrogen (BUN). A kidney biopsy is often performed to examine tissue samples under a microscope, revealing characteristic dense deposit formations and confirming the diagnosis. Additional tests may include complement levels and genetic studies to identify underlying immune dysregulation or mutations.
Treatment Protocols: Managing unspecified nephritic syndrome with dense deposit disease focuses on controlling symptoms and addressing the underlying immune abnormalities. Treatment options may include immunosuppressive medications, such as corticosteroids or other drugs targeting the immune response. Plasma exchange therapy can be used in some cases to remove abnormal immune factors. Blood pressure control with antihypertensive medications is essential to reduce kidney strain. Supportive therapies, such as diuretics or dietary modifications, may also be recommended. In severe cases, kidney transplantation might be considered, especially if kidney function declines significantly. Ongoing monitoring by healthcare providers is crucial to detect disease progression or complications early.
Clinical Advice & FAQs
Billing Guidance
Is N05.6 a billable ICD-10 code?
Yes, N05.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N05.6?
Clinical documentation must specify the nature of Unspecified nephritic syndrome with dense deposit disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference